v3.26.3
Capital Stock (Tables)
9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Schedule of Company’s Common Stock Purchase Warrants

A continuity schedule of the Company’s common stock purchase warrants for the three and nine months ended September 30, 2026, is as follows:

  

   Number of
Warrants
   Weighted Average
Exercise Price
   Weighted Average
Remaining Contractual Life (Years)
 
Balance at December 31, 2025   1,740,992   $13.00    0.31 
Exercised   (8,333)   13.00      
Balance at March 31, 2026   1,732,659    13.00    0.07 
Exercised   (447,504)   13.00      
Expired   (1,285,155)   13.00      
Balance at June 30, 2026 and September 30, 2026   -   $-    - 
Schedule of Weighted Average Basis Assumption Used in the Black-Scholes Option Pricing Model

  

         
   Nine Months Ended September 30, 
   2026   2025 
Risk Free Interest Rate   3.43%   - 
Expected Life in Years   3.00    - 
Expected Volatility   66.13%   - 
Expected Dividend Yield   0.00%   - 
Estimated forfeiture rate   0.00%   - 
Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity:

   

   Number of Stock Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (in years) 
Balance at December 31, 2025   425,300   $9.79    3.89 
Granted   10,000    11.67      
Forfeited   (5,800)   9.79      
Balance at March 31, 2026   429,500    9.84    3.67 
Balance at June 30, 2026   429,500    9.84    3.42 
Forfeited   (29,000)   9.81      
Balance at September 30, 2026   400,500   $9.84    3.18 
Schedule of RSUs Activity

The following table summarizes the Company’s RSUs activity:

  

   Number of RSUs   Weighted Average Grant-Date Fair Value 
Balance at December 31, 2025   19,950   $9.12 
Vested   (5,175)   9.36 
Forfeited   (500)   9.40 
Balance at March 31, 2026   14,275   $9.02 
Vested   (5,175)   9.36 
Balance at June 30, 2026   9,100    8.83 
Vested   (4,925)   9.36 
Forfeited   (500)   9.40 
Balance at September 30, 2026   3,675    8.04